Clinical Trial Update: Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of continuous temozolomide in patients with advanced or metastatic soft tissue sarcoma or metastatic breast cancer; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer, Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED